We have followed a customized and targeted gene panel NGS approach which could reach a close 80-90% detection rate of mutations in aldosterone-producing adenomas as a CYP11B2 IHC-guided targeted NGS approach (10, 31). Here, CYP11B2 is linked to adenoma.